COLORECTAL CANCER (CRC)

Clinical trials for COLORECTAL CANCER (CRC) explained in plain language.

Never miss a new study

Get alerted when new COLORECTAL CANCER (CRC) trials appear

Sign up with your email to follow new studies for COLORECTAL CANCER (CRC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 33 Not yet recruiting 11 Not yet finished but already full! 8 Completed 5 Terminated 1

Experimental KRAS blocker tested in advanced cancers – trial halted early

Disease control Terminated

This early-stage trial tested a new oral drug, AZD0022, designed to block the KRASG12D mutation found in some advanced cancers like lung, pancreatic, and colorectal cancer. The study aimed to see if the drug was safe and tolerable when given alone or with another cancer drug (cet…

Matched conditions: COLORECTAL CANCER (CRC)

Phase: PHASE1 • Sponsor: AstraZeneca • Aim: Disease control

Last updated Jun 27, 2026 11:03 UTC

COLORECTAL CANCER (CRC)

Get alerted when new COLORECTAL CANCER (CRC) trials appear

Experimental KRAS blocker tested in advanced cancers – trial halted early